AAAAAA

   
Results: 1-7 |
Results: 7
EFFICACY, SAFETY, AND DOSE-RESPONSE CHARACTERISTICS OF GLIPIZIDE GASTROINTESTINAL THERAPEUTIC SYSTEM ON GLYCEMIC CONTROL AND INSULIN-SECRETION IN NIDDM - RESULTS OF 2 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIALS
Authors: SIMONSON DC KOURIDES IA FEINGLOS M SHAMOON H FISCHETTE CT ARONOFF S BLONDE L CEFALU W CLEMENT S GREENBERG C LEVIN S LUCAS CP MACY C MANNING J MARBURY TC MCADAMS MJ MEZITIS NHE MILLER S OWENS D SANDLER J SCHWARTZ SL SHAMOON H SOSENKO J
Citation: Dc. Simonson et al., EFFICACY, SAFETY, AND DOSE-RESPONSE CHARACTERISTICS OF GLIPIZIDE GASTROINTESTINAL THERAPEUTIC SYSTEM ON GLYCEMIC CONTROL AND INSULIN-SECRETION IN NIDDM - RESULTS OF 2 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIALS, Diabetes care, 20(4), 1997, pp. 597-606
EXPLORATION OF SIMPLE INSULIN SENSITIVITY MEASURES DERIVED FROM FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE-TOLERANCE (FSIGT) TESTS - THE INSULIN-RESISTANCE ATHEROSCLEROSIS STUDY
Authors: ANDERSON RL HAMMAN RF SAVAGE PJ SAAD MF LAWS A KADES WW SANDS RE CEFALU W
Citation: Rl. Anderson et al., EXPLORATION OF SIMPLE INSULIN SENSITIVITY MEASURES DERIVED FROM FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE-TOLERANCE (FSIGT) TESTS - THE INSULIN-RESISTANCE ATHEROSCLEROSIS STUDY, American journal of epidemiology, 142(7), 1995, pp. 724-732
COMPARATIVE EFFICACY OF A ONCE-DAILY CONTROLLED-RELEASE FORMULATION OF GLIPIZIDE AND IMMEDIATE-RELEASE GLIPIZIDE IN PATIENTS WITH NIDDM
Authors: BERELOWITZ M FISCHETTE C CEFALU W SCHADE DS SUTFIN T KOURIDES IA
Citation: M. Berelowitz et al., COMPARATIVE EFFICACY OF A ONCE-DAILY CONTROLLED-RELEASE FORMULATION OF GLIPIZIDE AND IMMEDIATE-RELEASE GLIPIZIDE IN PATIENTS WITH NIDDM, Diabetes care, 17(12), 1994, pp. 1460-1464
HIGH-DOSE INTRAVENOUS, BUT NOT LOW-DOSE SUBCUTANEOUS, INSULIN-LIKE GROWTH-FACTOR-I THERAPY INDUCES SUSTAINED INSULIN SENSITIVITY IN SEVERELY RESISTANT TYPE-I DIABETES-MELLITUS
Authors: USALA AL MADIGAN T BURGUERA B CEFALU W SINHA MK POWELL JG USALA SJ
Citation: Al. Usala et al., HIGH-DOSE INTRAVENOUS, BUT NOT LOW-DOSE SUBCUTANEOUS, INSULIN-LIKE GROWTH-FACTOR-I THERAPY INDUCES SUSTAINED INSULIN SENSITIVITY IN SEVERELY RESISTANT TYPE-I DIABETES-MELLITUS, The Journal of clinical endocrinology and metabolism, 79(2), 1994, pp. 435-440
INTRAABDOMINAL FAT BY MRI SCANNING - RELATIONSHIP TO INSULIN-RESISTANCE AND AGE ACCORDING TO GENDER
Authors: WERBEL SS FAULK KL TERRY JG BELLFARROW AD WANG ZQ CROUSE JR CEFALU W
Citation: Ss. Werbel et al., INTRAABDOMINAL FAT BY MRI SCANNING - RELATIONSHIP TO INSULIN-RESISTANCE AND AGE ACCORDING TO GENDER, Diabetes, 43, 1994, pp. 10000053-10000053
GLIPIZIDE GITS VS IMMEDIATE-RELEASE GLIPIZIDE IN THE MANAGEMENT OF PATIENTS WITH NIDDM - EVIDENCE FOR INCREASED INSULIN SENSITIVITY AFTER GLIPIZIDE GITS TREATMENT
Authors: CEFALU W KOURIDES J FISCHETTE C
Citation: W. Cefalu et al., GLIPIZIDE GITS VS IMMEDIATE-RELEASE GLIPIZIDE IN THE MANAGEMENT OF PATIENTS WITH NIDDM - EVIDENCE FOR INCREASED INSULIN SENSITIVITY AFTER GLIPIZIDE GITS TREATMENT, Diabetes, 43, 1994, pp. 10000059-10000059
ADVANCED GLYCATION ENDPRODUCTS INDUCE NITRIC-OXIDE PRODUCTION IN MACROPHAGES OF NOD MICE
Authors: MOLLDREM J ROBINSON P CEFALU W WONG V SHERMAN M CLARESALZLER M
Citation: J. Molldrem et al., ADVANCED GLYCATION ENDPRODUCTS INDUCE NITRIC-OXIDE PRODUCTION IN MACROPHAGES OF NOD MICE, The Journal of immunology, 150(8), 1993, pp. 172-172
Risultati: 1-7 |